Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
G. Fattovich, G. Giustina, S. Favarato, A. Ruol, G. Macarri, F. Orlandi, et al.
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon.
J Hepatol, 24 (1996), pp. 38-47
[2.]
T. Okanoue, S. Sakamoto, Y. Itoh, M. Minami, K. Yasui, M. Sakamoto, et al.
Side effects of high-dose interferon therapy for chronic hepatitis C.
J Hepatol, 25 (1996), pp. 283-291
[3.]
M. Recasens, E. Aguilera, J.M. Sánchez-Tapias, S. Ampurdanés, O. Simó, R. Casamitjana, et al.
Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C.
Diabet Med, 18 (2001), pp. 764-767
[4.]
P. Fabris, A. Floreani, F. de Lazzari, C. Betterle, N.A. Greggio, R. Naccarato, et al.
Development of type 1 diabetes mellitus during interferon alpha therapy for chronic HCV hepatitis.
Lancet, 340 (1992), pp. 548
[5.]
A. Mofredj, M. Howaizi, D. Grasset, H. Licht, S. Loison, B. Devergie, et al.
Diabetes mellitus during interferon therapy for chronic viral hepatitis.
Dig Dis Sci, 47 (2002), pp. 1649-1654
[6.]
P. Fabris, A. Floreani, G. Tositti, D. Vergani, F. de Lalla, C. Betterle.
Review article: type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.
Aliment Pharmacol Ther, 18 (2003), pp. 549-558
[7.]
M.W. Fried.
Side effects of therapy of hepatitis C and their management.
Hepatology, 36 (2002), pp. 237-244
[8.]
F.I. Jabr, M.M. Ordinario.
Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy.
Am J Med, 115 (2003), pp. 158-159
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
